2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$10.47-$0.07 (-0.68%)
Price as of Sep 11, 2026 7:55 PM EDT- $806.9MMarket Cap
- 120.15%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$10.47-$0.07 (-0.68%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.54 | ||
Change | -$0.78 (-6.93%) | ||
Open | $11.32 | ||
High | $11.41 | ||
Low | $9.86 | ||
Previous Close | $11.33 | ||
Volume | 3,595,696 | ||
30-Day Average Volume | 1,387,405 | ||
1-Week Change | -17.49% | ||
1-Month Change | -0.99% | ||
1-Year Change | 120.15% | ||
3-Year Change | 778.75% | ||
5-Year Change | -3.26% | ||
Fundamentals | |||
Shares Outstanding | 76.5M | ||
Total Assets | $208.1M | ||
Market Cap | $806.9M | ||
Enterprise Value | $653.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.9M | ||
Free Cash Flow | -$17.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $191.5M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -20 | ||
PEG | 0 | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue